Stepan Company
1101 Skokie Blvd Ste 500 Northbrook
IL
60062-4126 United States

Stepan Company (SCL): A Bull Case Theory
We came across a bullish thesis on Stepan Company on Danny’s Substack’s Substack by Danny Green. In this article, we will summarize the bulls’ thesis on SCL. Stepan Company’s share was trading at $66.46 as of February 17th. SCL’s trailing and forward P/E were 33.73 and 19.01 respectively according to Yahoo Finance. Stepan Company operates across diversified chemical
Source: Insider Monkey Feb 28, 2026
Stepan (SCL) Launches Project Catalyst to Drive $100M in Cost Savings
Stepan Company (NYSE:SCL) is included among the 13 Most Promising Long-Term Stocks to Buy According to Hedge Funds. On February 23, Stepan Company (NYSE:SCL) announced Project Catalyst, which is a restructuring and efficiency initiative aimed at generating about $100 million in pre-tax savings over the next two years. The plan focuses on simplifying operations, reducing
Source: Insider Monkey Feb 25, 2026
3 Dividend Kings That Have Raised Payouts for 50+ Years and Still Look Cheap
Dividend King stocks are surprisingly cheap across the board because most investors are still heavily leaning on growth stocks. Stocks like Stepan Co (NYSE:SCL), Marzetti (NASDAQ:MZTI), and American States Water (NYSE:AWR) can get you both a handsome yield and healthy upside on top when the pendulum eventually swings the other way. If you expect the ... 3 Dividend Kings That Have Raised Payouts for 50+ Years and Still Look Cheap
Source: 24/7 Wall St. Feb 24, 2026
Why Stepan (SCL) Is Down 19.8% After Q4 Earnings, Goodwill Impairment And Cost-Saving Push
Stepan Company recently reported past fourth-quarter 2025 results, with sales of US$553.89 million and net income of US$5.00 million, booked a US$6.25 million goodwill impairment, and declared a quarterly dividend of US$0.395 per share payable on March 13, 2026. Alongside steady dividend growth for the 58th consecutive year, Stepan launched Project Catalyst and continued ramping up its new Pasadena alkoxylation facility, aiming for significant cost efficiencies and a sharper manufacturing...
Source: Simply Wall St. Feb 24, 2026
Stepan Co (SCL) Q4 2025 Earnings Call Highlights: Strong EBITDA Growth Amid Challenges
Stepan Co (SCL) reports a 6% increase in adjusted EBITDA and a positive free cash flow, while navigating raw material pressures and strategic facility closures.
Source: GuruFocus.com Feb 23, 2026
Stepan Q4 Earnings Call Highlights
Stepan (NYSE:SCL) executives used the company’s fourth-quarter and full-year 2025 earnings call to outline a year of portfolio actions, cost discipline, and improving cash generation, while also unveiling a new multi-year efficiency program dubbed Project Catalyst. Management frames 2025 as a “tran
Source: MarketBeat Feb 23, 2026
- Surfactants
- Specialty chemicals
- Phthalic anhydride
- Polyurethane polyols
- Cleaning agents
- Detergents
- Cleaning compounds
- Toothpaste
- Cosmetics
- Emulsifiers for agricultural insecticides
- Oil recovery agents
- Pharmaceutical polymers
- Food polymers
- Plastics materials
- Resins
- Synthetic rubber
- Artificial fibers
- Synthetic fibers
- Filaments
- Food additives
- Industrial chemicals
- Inorganic chemicals
- Soap
- Toilet preparations
- Surfactants
- Specialty chemicals
- Phthalic anhydride
- Polyurethane polyols
- Cleaning agents
- Detergents
- Cleaning compounds
- Toothpaste
- Cosmetics
- Toilet preparations
- Emulsifiers for agricultural insecticides
- Pharmaceutical polymers
- Resins
- Synthetic rubber
- Artificial fibers
- Synthetic fibers
- Filaments
- Food additives
- Soap
- Oil recovery agents
- Food polymers
- Plastics materials
- Industrial chemicals
- Inorganic chemicals
IndexBox is not affiliated with, associated with, or endorsed by this company in any way. The information provided on this page, including company details, is solely for informational purposes. IndexBox makes no representations or warranties about the accuracy or completeness of the information provided.
All data and information is provided “as is” for informational purposes only, and is not intended for trading purposes or financial, investment, tax, legal, accounting or other advice. Please consult your broker or financial representative to verify pricing before executing any trade. IndexBox is not an investment adviser, financial adviser or a securities broker. None of the data and information constitutes investment advice nor an offering, recommendation or solicitation by IndexBox to buy, sell or hold any security or financial product, and IndexBox makes no representation (and has no opinion) regarding the advisability or suitability of any investment.